C-rad -B trades -4.55 percent lower on Monday 26th of October
Explore C‑rad -B’s latest market dip, its 2026 outlook, and how its radiation‑therapy tech stands out in the healthcare equipment sector.
2 minutes to read
C-RAD AB-B SHS
CRAD‑B Sees 1.06% Gain Amid Q3 Revenue Dip; Share Repurchase Signals Confidence
Discover why C‑Rad AB’s Class B shares hit a modest 1.06 % gain despite a Q3 decline, and how the company’s strategy, backlog, and partnership with XECAN are shaping future growth in radiation‑therapy technology.
3 minutes to read